Machinery & Materials
Logistics & Cold Chain
CEVEC Pharmaceuticals, Catalent Pharma Solutions
More from CEVEC Pharmaceuticals, Catalent Pharma Solutions
CEVEC and Catalent Pharma Solutions Offer Joint Cell Line Development Service
CEVEC Pharmaceuticals, the German developer of a novel, market leading human protein expression system derived from amniocytes, and Catalent Pharma Solutions, a leading global drug development and delivery solutions provider, announced today a joint commercial cell line development service for pharma and biotech customers worldwide.
Jun 24th, 2011
InVivo and CEVEC sign license agreement for human CAP-TË Technology*
CEVEC Pharmaceuticals, the developer of a novel human expression system derived from amniocytes and the contract manufacturer InVivo BioTech Services GmbH announced today the signing of a strategic license agreement.
Oct 13th, 2009